Works by Johnston, Patrick B.

Results: 77
    1

    Long‐term outcome of immunologic autograft engineering.

    Published in:
    EJHaem, 2022, v. 3, n. 2, p. 488, doi. 10.1002/jha2.404
    By:
    • Porrata, Luis F.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Villasboas, Jose C.;
    • Paludo, Jonas;
    • Markovic, Svetomir N.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Targeted therapy in lymphoma.

    Published in:
    Journal of Hematology & Oncology, 2010, v. 3, p. 45, doi. 10.1186/1756-8722-3-45
    By:
    • Johnston, Patrick B.;
    • RuiRong Yuan;
    • Cavalli, Franco;
    • Witzig, Thomas E.
    Publication type:
    Article
    8
    9
    10

    Peak absolute lymphocyte count after CAR‐T infusion predicts clinical response in aggressive lymphoma.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 7, p. E241, doi. 10.1002/ajh.26561
    By:
    • Bansal, Radhika;
    • Novo, Mattia;
    • Al Saleh, Abdullah S.;
    • Guerrico, Anatilde Gonzalez;
    • Zhang, Henan;
    • Shao, Zuoyi;
    • Babadi, Elham;
    • Martinez, Kodi E.;
    • McCoy, Gabrielle A.;
    • Hathcock, Matthew A.;
    • Khurana, Arushi;
    • Bennani, Nabila Nora;
    • Paludo, Jonas;
    • Wang, Yucai;
    • Ansell, Stephen M.;
    • Johnston, Patrick B.;
    • Villasboas, Jose C.;
    • Lin, Yi
    Publication type:
    Article
    11
    12
    13

    Lines of therapy before autologous stem cell transplant and CAR‐T affect outcomes in aggressive Non‐Hodgkin's lymphoma.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 10, p. E386, doi. 10.1002/ajh.26293
    By:
    • Khurana, Arushi;
    • Hathcock, Matthew;
    • Habermann, Thomas M.;
    • Al Saleh, Abdullah S.;
    • Gandhi, Sangeetha;
    • Truong, Tuan;
    • Bennani, N. Nora;
    • Paludo, Jonas;
    • Villasboas, Jose C.;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Johnston, Patrick B.;
    • Micallef, Ivana;
    • Lin, Yi
    Publication type:
    Article
    14

    Role of systemic high‐dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990‐2018.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 3, p. 291, doi. 10.1002/ajh.25350
    By:
    • Castellino, Alessia;
    • Pulido, Jose S.;
    • Johnston, Patrick B.;
    • Ristow, Kay M.;
    • Nora Bennani, N.;
    • Inwards, David J.;
    • Macon, William R.;
    • Micallef, Ivana N. M.;
    • King, Rebecca L.;
    • Salomao, Diva R.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    15

    Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU)

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 10, p. 1004, doi. 10.1002/ajh.24824
    By:
    • Witzig, Thomas E.;
    • Johnston, Patrick B.;
    • LaPlant, Betsy R.;
    • Kurtin, Paul J.;
    • Pederson, Levi D.;
    • Moore Jr, Dennis F.;
    • Nabbout, Nassim H.;
    • Nikcevich, Daniel A.;
    • Rowland, Kendrith M.;
    • Grothey, Axel
    Publication type:
    Article
    16

    Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 448, doi. 10.1002/ajh.24671
    By:
    • Bennani, N. Nora;
    • LaPlant, Betsy R.;
    • Ansell, Stephen M.;
    • Habermann, Thomas. M.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Colgan, Joseph P.;
    • Markovic, Svetomir N.;
    • Nowakowski, Grzegorz S.;
    • Macon, William R.;
    • Reeder, Craig B.;
    • Mikhael, Joseph R.;
    • Northfelt, Donald W.;
    • Ghobrial, Irene M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    17

    Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non- Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 12, p. 1116, doi. 10.1002/ajh.23839
    By:
    • Witzig, Thomas E.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Markovic, Svetomir N.;
    • Johnston, Patrick B.;
    • Lin, Yi;
    • Thompson, Carrie;
    • Gupta, Mamta;
    • Katzmann, Jerry A.;
    • Cerhan, James R.
    Publication type:
    Article
    18

    A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and <sup>90</sup>yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 7, p. 589, doi. 10.1002/ajh.23460
    By:
    • Witzig, Thomas E.;
    • Wiseman, Gregory A.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Link, Brian K.;
    • Zent, Clive S.;
    • Johnston, Patrick B.;
    • Shanafelt, Tait D.;
    • Allmer, Cristine;
    • Asmann, Yan W.;
    • Gupta, Mamta;
    • Ballas, Zuhair K.;
    • Smith, Brian J.;
    • Weiner, George J.
    Publication type:
    Article
    19

    A Phase II study of <sup>153</sup>Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

    Published in:
    American Journal of Hematology, 2010, v. 85, n. 6, p. 409, doi. 10.1002/ajh.21696
    By:
    • Dispenzieri, Angela;
    • Wiseman, Gregory A.;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Kumar, Shaji K.;
    • Buadi, Francis;
    • Dingli, David;
    • Laumann, Krista M.;
    • Allred, Jake;
    • Geyer, Susan M.;
    • Litzow, Mark R.;
    • Gastineau, Dennis A.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Ansell, Stephen M.;
    • Porrata, Luis;
    • Elliott, Michelle A.;
    • Johnston, Patrick B.;
    • Hogan, William J.;
    • Gertz, Morie A.
    Publication type:
    Article
    20
    21
    22
    23
    24

    Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00895-7
    By:
    • Breen, William G.;
    • Young, Jason R.;
    • Hathcock, Matthew A.;
    • Kowalchuk, Roman O.;
    • Thorpe, Matthew P.;
    • Bansal, Radhika;
    • Khurana, Arushi;
    • Bennani, N. Nora;
    • Paludo, Jonas;
    • Bisneto, Jose Villasboas;
    • Wang, Yucai;
    • Ansell, Stephen M.;
    • Peterson, Jennifer L.;
    • Johnston, Patrick B.;
    • Lester, Scott C.;
    • Lin, Yi
    Publication type:
    Article
    25

    Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00777-4
    By:
    • Acosta-Medina, Aldo A.;
    • Johnson, Isla McKerrow;
    • Bansal, Radhika;
    • Hathcock, Matthew;
    • Kenderian, Saad J.;
    • Durani, Urshila;
    • Khurana, Arushi;
    • Wang, Yucai;
    • Paludo, Jonas;
    • Villasboas, Jose C.;
    • Bennani, N. Nora;
    • Johnston, Patrick B.;
    • Ansell, Stephen M.;
    • Lin, Yi;
    • Alkhateeb, Hassan B.
    Publication type:
    Article
    26
    27

    Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
    By:
    • Desai, Sanjal H.;
    • LaPlant, Betsy;
    • Macon, William R.;
    • King, Rebecca L.;
    • Wang, Yucai;
    • Inwards, David J.;
    • Micallef, Ivana;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    28
    29

    Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00452-0
    By:
    • Gile, Jennifer J.;
    • Lopez, Camden L.;
    • Ruan, Gordon J.;
    • Hathcock, Matthew A.;
    • Abeykoon, Jithma P.;
    • Heimgartner, Joy R.;
    • Baumann, Nikola A.;
    • McMahon, M. Molly;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Bisneto, Jose C. Villasboas;
    • Porrata, Luis F.;
    • Paludo, Jonas;
    • Ansell, Stephen M.;
    • Hogan, William J.;
    • Witzig, Thomas E.
    Publication type:
    Article
    30
    31

    Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report.

    Published in:
    Leukemia & Lymphoma, 2010, v. 51, n. 12, p. 2181, doi. 10.3109/10428194.2010.524329
    By:
    • Gertz, Morie A.;
    • Lacy, Martha Q.;
    • Dispenzieri, Angela;
    • Hayman, Suzanne R.;
    • Kumar, Shaji K.;
    • Dingli, David;
    • Ansell, Stephen M.;
    • Gastineau, Dennis A.;
    • Inwards, David J.;
    • Johnston, Patrick B.;
    • Litzow, Mark R.;
    • Micallef, Ivana N. M.;
    • Porrata, Luis F.;
    • Leung, Nelson;
    • Hogan, William J.;
    • Buadi, Francis K.
    Publication type:
    Article
    32

    Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone.

    Published in:
    Leukemia & Lymphoma, 2007, v. 48, n. 7, p. 1332, doi. 10.1080/10428190701435259
    By:
    • Simpson, Lijo;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Habermann, Thomas M.;
    • Inwards, David J.;
    • Ristow, Kay M.;
    • Johnston, Patrick B.;
    • Markovic, Svetomir N.;
    • Micallef, Ivana N.;
    • Porrata, Luis F.;
    • Witzig, Thomas E.
    Publication type:
    Article
    33
    34
    35

    Insurgent Compensation: Evidence from Iraq.

    Published in:
    American Economic Review, 2013, v. 103, n. 3, p. 518, doi. 10.1257/aer.103.3.518
    By:
    • Bahney, Benjamin W;
    • Iyengar, Radha K;
    • Johnston, Patrick B;
    • Jung, Danielle F;
    • Shapiro, Jacob N;
    • Shatz, Howard J
    Publication type:
    Article
    36
    37

    P1359: TUMOR‐SPECIFIC, T‐CELL‐TARGETING MICRORNA IS ASSOCIATED WITH CART CELL FAILURE IN B CELL MALIGNANCIES.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000972324.07303.db
    By:
    • Chohan, Karan;
    • Sirpilla, Olivia;
    • Leo Sakemura, R.;
    • Cox, Michelle;
    • Hefazi, Mehrdad;
    • Huynh, Truc;
    • Girsch, James;
    • Schick, Kendall;
    • Manriquez Roman, Claudia;
    • Stewart, Carli M.;
    • Yun, Kun;
    • Can, Ismail;
    • Ogbodo, Ekene J.;
    • Mai, Long;
    • Kimball, Brooke;
    • Ansell, Stephen M.;
    • Nora Bennani, N.;
    • Johnston, Patrick B.;
    • Paludo, Jonas;
    • Villasboas‐Bisneto, Jose C.
    Publication type:
    Article
    38
    39

    Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clinic experience.

    Published in:
    Leukemia & Lymphoma, 2024, v. 65, n. 3, p. 389, doi. 10.1080/10428194.2023.2285236
    By:
    • Chohan, Karan L.;
    • Bansal, Radhika;
    • Hathcock, Matthew A.;
    • Paludo, Jonas;
    • Bennani, Nora N.;
    • Johnston, Patrick B.;
    • Khurana, Arushi;
    • Durani, Urshila;
    • Wang, Yucai;
    • Ruff, Michael W.;
    • Villasboas Bisneto, Jose C.;
    • Ansell, Stephen M.;
    • Lin, Yi;
    • Kenderian, Saad S.
    Publication type:
    Article
    40
    41
    42

    A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 9, p. 2128, doi. 10.1080/10428194.2017.1416368
    By:
    • Sonbol, Mohamad Bassam;
    • Hilal, Talal;
    • Rosenthal, Allison C.;
    • Leis, Jose F.;
    • Northfelt, Donald W.;
    • Bergsagel, Peter Leif;
    • Reeder, Craig B.;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Conley, Christopher R.;
    • Gano, Katherine M.;
    • Nichols, Craig S.;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Inwards, David J.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.
    Publication type:
    Article
    43

    Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2014, v. 55, n. 12, p. 2728, doi. 10.3109/10428194.2014.893313
    By:
    • Porrata, Luis F.;
    • Ristow, Kay M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Nowakowski, Grzegorz;
    • Thompson, Carrie A.;
    • Markovic, Svetomir N.
    Publication type:
    Article
    44

    Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 11, p. 2159, doi. 10.3109/10428194.2012.690605
    By:
    • Porrata, Luis F.;
    • Ristow, Kay;
    • Habermann, Thomas M.;
    • Ozsan, Nazan;
    • Dogan, Ahmet;
    • Macon, William;
    • Colgan, Joseph P.;
    • Witzig, Thomas E.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Nowakowski, Grzegorz S.;
    • Thompson, Carrie;
    • Markovic, Svetomir N.
    Publication type:
    Article
    45

    Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.

    Published in:
    British Journal of Haematology, 2014, v. 165, n. 4, p. 510, doi. 10.1111/bjh.12780
    By:
    • Wang, Michael;
    • Popplewell, Leslie L.;
    • Collins, Robert H.;
    • Winter, Jane N.;
    • Goy, Andre;
    • Kaminski, Mark S.;
    • Bartlett, Nancy L.;
    • Johnston, Patrick B.;
    • Lister, John;
    • Fanning, Suzanne R.;
    • Tuscano, Joseph M.;
    • Beck, J. Thaddeus;
    • Kaya, Hakan;
    • Robeva, Anna;
    • Fan, Jenna;
    • Klimovsky, Judith;
    • Cheung, Wing;
    • Cherfi, Azzeddine;
    • O'Connor, Owen A.
    Publication type:
    Article
    46
    47
    48
    49
    50

    Absolute lymphocyte count predicts overall survival in follicular lymphomas.

    Published in:
    British Journal of Haematology, 2006, v. 134, n. 6, p. 596, doi. 10.1111/j.1365-2141.2006.06232.x
    By:
    • Siddiqui, Mustaqeem;
    • Ristow, Kay;
    • Markovic, Svetomir N.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • White, William L.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Call, Timothy G.;
    • Porrata, Luis F.
    Publication type:
    Article